News

LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.

The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.

Technology using 'programmable droplets' could enable automated research on a grand scale.

Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.

An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.

A newly devised algorithm called LogicTRN has the potential to unravel the complexities of genetic regulation.

The Salk Institute and Indivumed GmbH, a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting-edge basic and translational research in cancer.

Water contaminated by the oil currently leaking into the ocean from the Sanchi tanker collision is likely to take at least three months to reach land, and if it does the Korean coast is the most likely location. However, the oil’s fate is highly uncertain, as it may burn, evaporate, or mix into the surface ocean and contaminate the environment for an extended duration.

Genohm and iSpecimen have jointly announced that Genohm has established a partnership with iSpecimen to enable users of the SLIMS laboratory information management system to seamlessly connect to the iSpecimen Marketplace.